Note : Les descriptions sont présentées dans la langue officielle dans laquelle elles ont été soumises.
11334~37
~1'-
OCTAHYDRO P~RAZOLO ~3,4~g~ QUINOLINES
This invention, in one aspect, provides octahydro-
pyrazolo~3,4-g~quinolines of the genreal formula:
~!r~ ~ U ~/ ~
Ia
wherein
R is (Cl-C3)alkyl or allyl;
R is H or CH2X wherein X is OCH3, SC~3, CN, SO2CH3
or CONH2; and
pharmaceutically-acceptable acid addition salts
thereof.
The compounds of formulae Ia and Ib above are pre-
pared by reacting a compound of the general formula
~ /~\H ~-~ Rl'
t i i VIIIa
(CH3~2NCH \./ H
wherein
R' is H, CN, (Cl-C3)alkyl Gr allyl;
30 Ql O
R is H, -COOH, -C-O(Cl-C2)alkyl, -C-O-substituted-
(Cl-C2)alkylphenyl;
1133~
. ~2-
with h.ydrazine fiydrate;
followed ~y, when R is CN, reacting with zinc and
acetic acid to form the compounds where R is H;
followed by, when R is H, reacting with an alkyl or
allyl halide or reductive alkylation with an appropriate alde-
hyde and metal hydride to obtain the compounds of formulae Ia
and Ib. where R is (:Cl-C3)alkyl or allyl;
followed by, when Rl is other than H, reacting with a
metal hydride to obtain the intermediate compounds of formulae
Ia and Ib wherein Rl is CH2OH:, followed by reacting with a
nucleophilic reagent to obtain the intermèdiate compounds of
formulae Ia and Ib wherein Rl is CH2Y where Y is Cl, sr, OSO2-
phenyl, O-tosyl, or OSO2(Cl-C3)alkyl, followed by reacting with
sodium methylate, meth.yl mercaptan sodium salt, sodium cyanide,
sodium methanesulfinate, to obtain the compounds of formulae Ia
and Ib wherein Rl is CH2X where X is CN, SCH3, SO2CH3, or CH3; and
optionally followed by reaction the compounds of
formulae Ia and Ib where Rl is CH2CN with hydration to obtain
the compounds of formulae Ia and Ib where Rl is CH2CONH2, and
where desired, forming pharmaceutically acceptable acid addition
salts of the aforesaid compounds of formulae Ia and Ib.
The compounds of formulae Ia and Ib, together with
their pharmaceutically-acceptable salts thereof, are useful
chiefly as dopamine agonists.
Said compounds of formulae Ia and Ib and their pharma-
ceutically acceptable salts, and the process for their prepara-
tion, are disclosed and are also claimed in our Canadian Applica-
tion No. 33G,552, filed June 26, 1979, of which the present
application is a divisional.
~3~
-3-
Also provided by the invention, in another aspect,
are intermediates of the following general formulae:
ii"~ /\C 1
1~ Ic Id
w-herein
is H:, CN, Cl-C3alkyl or benzyl;
R is H, -COOH:, -coo(cl-C3)alkyl, or CH2X
wherein X is Cl, Br, I, OH, oSO2-(C1-C3)alkyl, OS02tolyl~ or
OSO2phenyl;
with the proviso that when R is Cl-C3alkyl, then
can not be H; and
the salts thereof.
All salts of these intermediates are useful in purification or
synthetic procedures.
This invention, in still another aspect, further pro-
vides a process for preparing the above intermediates of formulae
Ic and Id wherein
R is H, CN, Cl-C3alkyl or benzyl;
R is H, -COOH, -COO(Cl-C3)alkyl~ or CH2X
: wherein X is Cl, Br, I, OH, OSO2-(Cl-C3)alkyl, OSO2tolyl, or
S02phenyl;
with the proviso that when R is Cl-C3alkyl, then
can not be H; and
the salts thereof, which comprises reacting a compound
of the general formula
H
~ f \ 4
(CH3~2NCH='\ /j
~ H
113~7
-3a-
~herein
R ~s defined as above; and
R is H-or COOZ~ where Z~ is H, or ~Cl-C3~alkyl,
w-itfi hydrazine hydrate;
followed by, when Z~ is ~Cl-C3)alkyl, reacting with a
metal hydride to obtain t~e compounds where Rl is CH2OH,
followed by, if desired, reacting with a nucleophilic reagent
to obtain the compounds where Rl is CH2Y where Y is Cl, Br, I,
OSO2-(Cl-C3)alkyl, OSO2tolyl or OSO2phenyl and where desired,
forming a salt of said compound of general formula Ic or Id.
The above intermediates of general formulae Ic and Id,
and salts thereof, and the process for their preparation, are
disclosed and are also claimed in Canadian Application No.
37~,574, filed June 11, 1~81, a divisional of the aforesaid
15 Canadian Application No. 330,552.
In t~e above formulas, the term "(Cl-C2)alkyl" in-
cludes methyl and ethyl and "(Cl-C3)alkyl" includes also n-
propyl and isopropyl. The term "tolyl" includes p, m and o-
tolyl.
The pharmaceutically-acceptable acid addition salts
of formulae Ia-Id include salts derived from inorganic acids
such as: hydrochloric acid, nitric acid, phosphoric acid, sul-
furie acid, hydrobromie aeid, hydriodie aeid, nitrous aeid,
phosphorous aeid and the like, as well as salts derived from
nontoxie
3~
-4-
or~anic acids such as aliph~tic mono and dicarboxylic acids,
pXenyl-substituted alkanoic acids, hydroxy alkanoic and alkandioic
acids, aromatic acids, aliphatic and aromatic sulfonic acids.
Such pharmaceutically-acceptable salts thus include sulfate,
p~rosulfate, bisulfate, sulfite, bisulfite, nitrate, phosphate,
monohydrogenphosphate, dihydrogenphosphate, metaphosphate, pyro-
phosphate, chloride, bromide, iodide, fluoride, acetate, propion-
ate, decanoate, caprylate, acrylate, formate, isobutyrate, caprate,
heptanoate, propiolate, oxalate, malonate, succinate, suberate,
lQ sebacate, fumarate, maleate, mandelate, butyne-1,4-dioate,
hexyne-1,6-dioate, benzoate, chlorobenzoate, methylbenzoate, di-
nitrobenzoate, hydroxybenzoate, methoxybenzoate, phthalate, tere-
phthalate, benzenesulfonate, toluenesulfonate, chlorobenzenesul-
fonate, xylenesulfonate, phenylacetate, phenylpropionate, phenyl-
butyrate, citrate, lactate, ~-hydroxybutyrate, glycollate,
malate, tartrate, methanesulfonate, propanesulfonate, naphtha-
lene-l-sulfonate, naphthalene-2-sulfonate and the like salts.
Compounds according to Ia above are named systematicallv
as 4,4a,5,6,7,8,8a,9-octahydro-lH-pyrazoloF3,4-g~quinolines and
those according to Ib as 4,4a,5,6,7,8,8a,9-octahydro-2H-
pyrazolo ~,4-g~ quinolines. These two structures represent a
tautomeric pair and the tautomers represented by the structures
are in dynamic equilibrium. In addition, compounds represented
by formulas Ia and Ib above when R is H have two chiral centers,
the ring junction
..
11334E~7
~5~
carbons at 8a and 4a. Thus, the compounds can occur as two
racemates, ordinarily deno~inated as the trans-dl racemate and
the cis-dl racemate. It is believed, however, according to the
best evidence from 13C NMR spectral data, that the cyanoboro-
hydride reduction process which introduces hydrogens at thequinoline bridge-head, a step in the synthetic procedure used to
prepare the compounds of formulae Ia and Ib, yields a trans-
fused decahydroquinoline. While the arguments for the trans con-
figuration based upon 13C NMR spectral data are compelling, an
X-ray crystallographic investigation has also been carried out on
a nicely crystalline enaminoketone in the decahydroquinoline
series (VIII, R CH3). This X-ray analysis indicates clearly that
the ring junction in the quinoline moiety is trans. Further
operations on the decahydroquinoline molecule to condense a
pyrazole ring thereon do not alter the configuration of the l~
- bridge-head hydrogens. Thus, only the trans racemate is prepared
by the synthetic procedures to be disclosed hereinafter and the
compounds of formulae Ia and Ib are preferably represented as
the trans-dl stereoisomers. The two trans stereoisomers of the
2Q 2H tautomer can ~e represented as follows:
HN/ j f ~ and H~CH~ f t
~./H;\N / H
IIa IIb
11334~7
IIa and IIb represent a racemic pair. A similar
racemic pair can be drawn for the lH tautomer.
R R
lQ IIc IId
IIc and IId also represent a racemic pair.
Resolution of these racemates into their
optical antipodes can be accomplished by procedures
known to those skilled in the art, and the individual
trans-d and trans-1 isomers are included within the
scope of this invention.
In addition, when Rl is other than H, a
third chiral center is introduced at C-7. However, it
i= presently believed that the configuration of the
C-7 group is chiefly beta relative to an alpha 8a
hydrogen as in IIa. In the mirror image, IIb, Rl is
alpha with respect to 8a being beta. Thus, the
trans-dl 7-substituted octahydropyrazolo[3,4-g]~uino-
lines of formulae Ia and Ib are provided substantiallyas a single racemate or diastereoisomeric pair.
The following compounds illustrate some
of formulae Ia and Ib:
trans-dl-5-methyl-7-methoxy~ethyl-4,4a,5,-
6,7,8,&a,9-octahydro-2H-pyrazolo[3,4-g]quinoline,
3 3
-7-
trans-Q-5-allyl-7-methylmercaptomethyl-
4,4a,5,6,7,8,8a,9-octahydro-2H-pyrazolo[3,4-
g~quinoline maleate,
trans-dl-5-ethyl-4,4a,5,6,7,8,8a,9-
octahydro-lH-pyrazolo[3,4-g]quinoline,
trans-dl-5-n-propyl-7-methylsulfonyl-
methyl-4,4a,5,6,7,8,8a,9-octahydro-lH-pyrazolo-
[3,4-g]guinoline tartrate,
trans-d-5-methyl-7-cyanomethyl-4,4a,-
5,6,7,8,Ba,9-octahydro-lH-pyrazolo[3,4-g]quinoline,
trans-dl-5-methyl-4,4a,5,6,7,8,8a,9-
octahydro-2H-pyrazolo[3,4-g]quinoline sulfate,
trans-dl-4,4a,5,6,7,8,8a,9-octahydro-
lH-pyrazolo[3,4-glquinoline sulfate,
trans-dl-5-n-propyl-7-carboamidomethyl-
4,4a,5,6,7,8,8a,9-octahydro-2H-pyrazolo[3,4-
g]quinoline fumarate,
trans-dl-5-isopropyl-4,4a,5,6,7,8,8a,9-
octahydro-2~-pyrazolol3,4-g]quinoline,
trans-dl-7-methylmercaptomethyl-4,4a,-
5,6,7,8,8a,9-octahydro-lH-pyrazolo[3,4-g]quinoline,
trans-dl-5-n-propyl-7-methoxymethyl-
4,4a,5,6,7,8,8a,9-octahydro-2H-pyrazolo[3,4-
g]quinoline maleate,
trans-dl-5-ethyl-7-cyanomethyl-4,4a,-
5,6,7,8,8a,9-octahydro-2H-pyrazolol3,4-g]quinolin~, and
trans-dl-5-allyl-4,4a,5,6,7,8,8z,9-
octahydro-2H-pyrazo'ol3,4-g~quinoline.
For compounds listed above, it should be
understood that each name also comprehends the cther
tauto~er since an equilibrium mixture of the two
._.
1133~
tautomers is always present. The 2H tautomer
apparently predominates in several of the tautomeric
mixtures. In addition, the orientation of substitu-
ents is not given, nor is the configuration of the
hydrogens at 4a and 8a, but it is understood that the
hydrogens are trans to one another and that the 7
substituent is "trans" to the 8a hydrogen; i.e., when
the 8a hydrogen is alpha, the 7 substituent is beta
and when the 8a hydrogen is beta, the 7 substituent is
oriented in the alpha configuration.
- The compounds of formulae Ia and Ib in
which Rl is H are prepared according to the following
procedure as outlined in Reaction Scheme I. In the
Reaction Scheme, only one stereoisomer of the racemic
pair, the 4a~, 8a~ isomer, has been drawn for con-
venience but it should be remembered that each deca-
hydroquinoline and each octahydropyrazolo[3,4-g]
quinoline exists as a racemate.
1133~7
Reaction scheme I
o
I t pyrrolidine \ acrylamide \
\~/ acid catalyst /
Z--CO--O--t/ \t/ \t
O-CO-Z \;/ \~ 0
III H
RX I NaH
z
CO
t. . I , LiAlH4 0- ~/ \t \ ~
V R IV R
HCI
\ NaCNBH3
H0-~/ ~ \, C 0 \ ~I' `~' `I
VI R R
CH ~ /~ / 0~ (CH;)2NCH(OZ'')
IXa- H~ / (CH3)2~CH~
/l\ R ~ VIII
" NH2NH2-H20
~=I'"`'--f`I
~H= \ /~
IX R
- il33487
--10--
In the above reaction scheme, Z-CO is an acyl pro-
tecting group in which Z is (Cl-C3)aikyl, (C2-C3)-
alkenyl, (C2-C3)alkynyl, (C5-C6)cycloalkyl, phenyl or
substituted phenyl wherein the substituting group can
be methyl, methoxy, chloro and the like at any position
of the phenyl ring. Illustratively, Z-CO can be
acetyl, propionyl, butyryl, propiolyl, acrylyl,
benzoyl, p-toluyl, o-chlorobenzoyl, m-methoxybenzoyl,
and so on.
Z " is defined hereinbelow in the discussion
of Reaction Scheme II. In accordance with Reaction
Scheme I, 4-acyloxycyclohexanone prepared by the
procedure of E.R.H. Jones and F. Sondheimer, J. Chem.
Soc., 615, (1949) for 4-benzoyloxycyclohexanone, is
reactsd with pyrrolidine in the presence of an acid
catalyst to yield the pyrrolidine enamine. This
enamine i3 in turn reacted with acrylamide to produce
a mixtu-e of dl-6-acyloxy-3,4,5,6,7,8-hexahydro-
2(lH)quinolinone and dl-6-acyloxy-3,4,4a,5,6,7-hexa-
2G hydro-2(1~)quinolinone represented by formula III, the
dotted lines indicating the alternative positions of
the double bond.
Next, the acidic nitrogen (acidic since it
is alpha to a carbonyl group) is alkylated with an
alkyl halide RX wherein R has the same meaning as
hereinabove and X is a halogen such as Cl, Br or I, in
the presence of sodium hydride to yield a mixture of
dl-l-(Cl-C3) alXyl (or allyl or benzyl)-6-acyloxy-
3,~,5,6,7,8-hexahydro-2(lH) quinolinone and its ~
3C isom~r (IV). Reduction of this amide with lithl~m
1 133~7
aluminum hydride or other suitable organometallic
reducing agent yields a mixture of dl-l-(Cl-C3)alkyl-
(or allyl or benzyl)-6-hydroxy-1,2,3,4,5,6,7,8-
octahydroquinoline and its Q8 isomer. In this re-
action mixture, conditions are encountered which alsoserve to hydrogenolyze the acyloxy group to a hydroxyl
group at C-6. This dl-l-(Cl-C3~alkyl (or allyl or
benzyl)-6-hydroxyoctahydroquinoline is next converted
to an ammonium salt by treatment with hydrochloric
1~ acid, and the ammonium salt is then reduced with
sodium cyanoborohydride to yield trans-dl-l-(Cl-C3)-
alkyl (or allyl or benzyl)-6-hydroxydecahydroquinoline
(VI). Next, the trans-dl-l-(Cl-C3 alkyl, allyl, or
benzyl)-6-hydroxydecahydroquinoline (VI) is oxidized
using, preferably, chromium trioxide in acetic acid,
to yield the corresponding 6-oxo compound (VII). This
6-oxo compound (VII) is reacted with dimethylformamiZe
dimethylacetal to yield a 7-dimethylaminomethylene-
6-oxo-derivative (VIII). Reaction of this derivative
with hydrazine hydrate yields a tautomeric mixture of
a tricyclic derivative, predominately trans-dl-5-
[~Cl-C3~alkyl, allyl or benzyl)3-4,4a,5,6,7,8,8a,9-
octahydro-2H-pyrazolo[3,4-g3quinoline (IX) and its lH
tau~omer (IXa) in smaller amount.
The compounds of formulae Ia and Ib wherein
R is Cl-C3 alkyl or allyl, the dcpamine agonists, can
also be prepared from compounds in which ~ is benzyl.
In this procedure, the benzyl group is removed by
reductive cleavage or by treatment ~ith cyanogen
3~ bromide to yield, eventually, a compound according to
~133~
-12-
IX or IXa in which R is H progressing thru an inter-
mediate when cyanogen bromide is used in which R is
CN. This debenzylated compound can then be alkylated
with a lower alkyl halide, or alternatively it may be
reductively alkylated using acetaldehyde, acrolein or
propionaldehyde in each instance with a metal hydride,
such as sodium cyanoborohydride, to yield the desired
N-alkyl or allyl derivative. The usual conditions for
removing an N-benzyl group are hydrogen with a palladium-
on-carbon catalyst or reaction with cyanogenbromide
followed by reductive (Zn and acetic acid) cleavage of
the N-cyano compound.
In the above reaction scheme, it is apparent
from an inspection of the dl-trans-l(substituted)-6-
ketodecahydroquinoline (VII) that reaction withdimethylformamide dimethylacetal could take place at
either C-5 or C-7 since both these carbons are alpha
to the ketone group and thus available for reaction.
The sa~e X-ray crystallographic analysis of the
ena~ine (VIII) discussed above clearly indicated that
reaction had taken place at C-7 rather than C-5.
Hence, the final tricyclic compounds, IX and IXa, are
the linear pyrazolol3,4-g]quinolines rather than the
angular tricyclic compounds (which would be named as
4,4a,5,6,7,8,8a,9-octahydro-lH-pyrazolo[2,3-i]quino-
lines.
The compounds of this invention in which
is other than H zre prepared accordins to a slightly
different procedure illustrated generally in Reaction
Scheme II. ~s in Reaction Scheme I the procedure is
exemplified with only (referring to the stereochem-
istry of the bridge-head) a single stereoisomer~ the
4a~, 8aa iso~er.
~1339~8;'
Reaction Scheme II
' O .- ~
'r
RNH2 \ ~ / \t COOZ
s~ ,I CH2=C--COOZ' , ~;i \N
I CH2Ha I X
O-CO-Z R
ac i d
BH4
lC /
~ H
HO-~ ~-- COQZ ' / EtOH / OH \~ \~ \t-- COOZ '
N \ HC I \ \ ~i N
XII R XI R
pyr i d i ne HC I
CrO3
\ /
2~ ~ H ~
0=~ ~ ~-- COOZ' (CH3 ) 2NCH (OZ ' ' ) 2
H `N O= ` \~-- COOZ '
XIII (CH3) 2NCHs~
XIV R
¦ NHzNH2-H20
~ /
h -
-:_. XV R
~,
','~
li3~
-14-
wherein Z and Z'' have the same significance as in
Reaction Scheme I, Hal is chloro or bromo and Z' is
part of a readily hydrolyzable group Z'O-CO such as
(Cl-C2)alkyl, phenyl substituted-(Cl-C2)alkyl, illus-
tratively benzyl, phenethyl, p-methoxybenzyl, methyl,
or ethyl.
In accordance with the Reaction Scheme II,
a 4-acyloxycyclohexanone is reacted with an a-halo-
methylacrylate ester, for illustrative purposes, the
ethyl ester and an amine, RNH2, wherein R is Cl-C3
alkyl, allyl or benzyl. The product of this reaction
is a mixture of dl-l-substituted-3-ethoxycarbonyl-
6-acyloxy-1,2,3,4,5,6,7,8-octahydroquinoline and
dl-1-substituted-3-ethoxycarbonyl-6-acyloxy-1,2,-
3,4,4a,5,6,7-octahydroquinoline represented by X in
which the dotted line indicates the alternate positions
of the double bonds. The hydrochloride salts of these
isomers were prepared and the resulting mixture re-
duced with sodium cyanoborohydride to yield trans-dl-
1-subctituted-3-ethoxycarbonyl-6-acyloxydecahydro-
quinoline (XI). Hydrolysis of this diester to yield a
6-hydroxy-3-carboxylic acid followed by reesterifi-
cation of the carboxylic acid group with ethanol or
other suitable alcohol in the presence of acid yields,
as a novel intermediate, trans-dl-l-substituted-
3-ethoxycarbonyl-6-hydroxydecahydroquinoline (XII).
~xidation of the hydroxy group with Sarett's Reagent
(pyr.dine hydrochloride and chrcmium trioxide) pro-
duces tne corresponcing novel intermeaiate 6-oxo
compound (XIII). Treatment of this 6-oxo derivative
113~37
-15-
with a dimethylformamide acetal, preferably dimethyl-
formamide dimethylacetal, results in reaction at C-7
(adjacent to the keto group) to give, as a novel
intermediate, trans-dl-l-substituted-3-ethoxycarbonyl-
6-oxo-7-(dimethylaminomethylene)decahydroquinoline
(XIV). Reaction of this derivative as in Reaction
Scheme I above with hydrazine hydrate results in a
mixture comprising trans-dl-5-substituted-7-ethoxy-
carbonyl-4,4a,5,6,7,8,8a,9-octahydro-lH-pyrazolo-
13,4-glquinoline and its 2H tautomer (represented by
XV as a single stereoisomer). The compound can be
isolated and purified as the free base or as the
dihydrochloride salt, prepared according to conventional
procedures.
Acetals of dimethylformamide useful in
producing compound VIII in Reaction Scheme I and
compound XIV in Reaction Scheme II have the general
formula (CH~)2N-CH-(OZ'')2 in which Z'' is (Cl-C~)-
alkyl, (C5-C6)cycloalkyl, (C3-C4)alkenyl, (C3-C4)-
alkynyl and the like. We prefer to employ one of
the commercially a~ailable acetals of dimethyl-
formamide; l.e.; the dimethyl, diethyl, diisopropyl,
dibutyl, dicyclohexyl, dipropyl or dineopentyl
acetals.
In formula XV above, R is (Cl-C3)alkyl,
allyl or benzyl. The octahydropyrazolo[3,4-g]-
~uinoline of Formula XV represents a single tau-
tomer, the 2H tautomer, and only one diastereo-
isomer. The mirror image of ~V is also prepared and
is included within the scope of this invention. We
11334~'7
-16-
bel~eye hased upon analogy with the D-ergolines that the dia-
stereoisomer XV is the isomer having dopamine agonist activity.
The trans-dl racemate, which contains XV and its mirror image,
is of course useful as a dopamine agonist, even though most of
the desired activity resides in one of its component stereoiso-
mers.
I:ntermediates described in Reaction Schemes I and II,
having the following structures, form a part of this invention
10. HO-I ~ ~-Rl o--~\f ~_Rl O=~ \ ~ ~R
and (CH3)2N-CH~
R R R
XII XIII XIV
wherein R is (Cl-C3)alkyl, allyl or benzyl and Rl is COOZ'
wherein Z' i5 (Cl-C2)alkyl or phenyl-substituted (Cl-C2)alkyl.
These intermediates are prepared by the methods set forth in
those reaction schemes, in the accompanying detailed description
and in the Examples which follow.
The invention, then, in a further aspect, resides in
an intermediate compound of the formula
O~ -R
(CH3)2N-CH~.~ ~ ~ ; XIV
N
R
wherein R is (Cl-C3)alkyl, allyl or benzyl and Rl is COOZ'
wherein Z' is ~Cl-C2)alkyl, benzyl, phenethyl or p-methoxybenzyl;
and in a process for preparing this intermediate which comprises
reacting a compound of the formula
1~ ~
11334~
~16a
Q;~ji\~-/ \~~COOZ~
~ /i\N/ XIII
wherein R and Z~ are defined as before, with dimethylformamide
dimethylacetal.
Compounds according to formula XV above in which R is
ethyl, allyl or n-propyl can be prepared by two different pro-
cedures. First, the amine , RNH2, used in preparing X can be
ethyl, n-propyl or allyl thus introducing the group directly.
Alternatively a compound according to formula XV in which R is
methyl or benzyl can be transformed into a compound in which R
is H by removing the methyl or benzyl group by reaction with
cyanogen bromide. The intermediate
11334~17
5-cyano (R is CN) derivative can be reductively
cleaved (zinc plus acetic acid) to yield a compound in
which R is H. In addition, the benzyl group can be
removed by hydrogenation with palladium-on-carbon to
yield those intermediates in which R=H. Alkylation of
the secondary amine can be accomplished by reaction
with an alkyl halide--RCl, RBr or RI. Alternatively,
the secondary amine group can be reacted with an
aldehyde, such as acetaldehyde, acrolein, or pro-
pionaldehyde under reducing conditions with a meta~hydride, (e.g. NaBH3CN) to yield an N-ethyl, N-allyl
or N-n-propyl derivative.
The dopamine agbnists of this invention,
those compounds of formulae Ia and Ib in which Rl is
CH2X wherein X is CN, OCH3, SCH3, SO2CH3 or CO-NH2,
are prepared from compound XV according to Reaction
Scheme III below
1133~8
--18--
Reaction Scheme III
i~r
LiAlH ~ XV
\ /
~ ~H~f~lXVI
tOSY I -C I SOC I 2
(Cl-C3)a I kyl SO2CI PCI 5
p he ny I SO2C I POC I 3
PBr3
\ Etc .
~ H;
NaCN
2 5 CH~SNa
CH30Na
\ CH3SO2Na
~N--=~ CHs2X
`l XVIII
R
4~
--19--
wherein Y is a "leaving" group: Cl, Br, OSO2phenyl,
O-tosyl or SO2(Cl-C3)alkyl, R2 is H, SO2phenyl, tosyl
or SO2(Cl-C3)alkyl, and X is CN, SCH3, OCH3 or SO2CH3.
In Reaction Scheme III, as before, only one
tautomer, the 2H tautomer, is illustrated. Further-
more, the 2H tautomer exists as a racemate and only
one diastereoisomer is illustrated, the 4a~, 7~, 8a~
isomer. The mirror image compound is, of course, also
produced since it constitutes half of the starting
material, XV. The trans-dl racemates of XVIII are
useful as dopamine agonists because of their content
of active agonist. The intermediate racemates, XV,
XVI and XVII are useful in that each contains a
diastereoisomer which can be chemically transformed to
an active dopamine agonist.
According to Reaction Scheme III, a trans-
dl-5-substituted-4,4a,5,6,7,8,8a,9-octahydro-2H-
pyrazolo~3,4-g]quinoline-7-carboxylate ester is
reduced with a metal hydride reducing agent, such as
LiAlH4, to a pyrazolo~3,4-g]quinoline with a 7-
hydroxymethyl group (XVI). The thus-produced
hydroxyl is next replaced with a "leaving group";
i.e., a group readily displaced by a nucleophilic
reagent, including chlorine, bromine and the
halogen-like esters, tosylate (usually p-toluene
sulfonate), alkyl sulfonate, benzene sulfonate to
produce a compound of structure XVII. The Cl or Br
leaving groups are introduced by reaction with PC13,
SOC12, PC15, POC13, PBr3 and the like, and the
11334~7
-20-
sulfonate esters by reaction with the corresponding
sulfonyl chloride. Reaction of XVII with sodium
methylate, methylmercaptan sodium salt, sodium cyanide,
sodium methanesulfinate or other basic salts of
methanol, methylmercaptan and so forth yields com-
pounds according to formula Ia, Ib, Ic or Id in which
X is SCH3, OCH3, CN or SO2CH3. These basic reaction
conditions also serve to hydrolyze the sulfonyl group
in the pyrazole ring, if any, to produce a tautomeric
mixture XVIII lof which only the 2-tautomer is illus-
trated). Compounds in which X is CONH2 are prepared
by hydration of the corresponding cyano compound.
This invention is further illustrated by the
following specific examples.
STARTING MATERIALS
Example A
Preparation of trans-dl-5-Cyano-4,4a,5,6,7,8,8a,9-
octahydro-lH (and 2H)-pyrazolo[3,4-g]quinoline
A reaction mixture was prepared from 65 g.
of 4-benzoyloxycyclohexanone, 38 ml. of pyrrolidine,
a few crystals of p-toluenesulfonic acid monohydrate,
and 1000 ml. of benzene. The reaction mixture was
heated to refluxing temperature under a nitrogen
atmosphere for one hour in an apparatus equipped with
a Dean-Stark water trap. The reaction mixture was
then cooled and the volatile constituents removed by
evaporation in vacuo. The residue, comprising the
pyrrolidine enamine of 4-benzoyloxycyclohexanone
11~3~
formed in the above reaction, was dissolved without
further purification in 1000 ml. of dioxane. 64 g. of
acrylamide were added. This new reaction mixture was
heated under a nitrogen atmosphere at reflux tem-
perature for two days after which time it was cooledand the volatile constituents removed by evaporation
in vacuo. The reaction mixture was diluted with ethyl
acetate and the ethyl acetate layer separated, washed
first with water and then with saturated aqueous
sodium chloride. The ethyl acetate layer was dried
and the volatile constituents removed by evaporation
in vacuo. The resulting residue, comprising a mixture
of 2-oxo-6-benzoyloxy-3,4,5,6,7,8-hexahydroquinoline
and 2-oxo-6-benzoyloxy-3,4,4a,5,6,7,-hexahydroquinoline
formed in the above reaction, was dissolved in chloro-
form ar.d ~he chloroform solution chromatographed over
"~Lorisil" CAloroform containing increasing amounts of
etnanol (0 to 2 percent~ was used as the eluant.
Fractions found to contain 2-oxo-6-benzoyloxy-
2C 3,4,5,6,7,8-hexahydroquinoline and its ~8(8a) isomer
by thin-layer chromatography were combined and the
solvent remcved therefrom in vacuo. The resulting
res-due was crystallized by triturating with hexane to
yield a crystalline mixture of 6-benzoyloxy-3,4,5,6,7,8-
hexahydro-lH-quinolin-2-one and the corresponding
3,4,4a,5,6,7-hexahydro derivative. The mixture melted
in the range 130-150C. after recrystallization from
an etAer-hexane solvent mixture.
~ Analys s:Calculated: C, 70.83; H, 6.32; N, 5.16.
Found: C, 71.05; H, 6.19; N, 5.33.
*Trademark for activated magnesium silicate in the form
of hard, porous, stable, white granules, used as an
adsorbent in chromatographic separations.
~13~3~
-22-
NMR of the product isolated above indicated
that the mixture contained about 60 percent of 6-
benzoyloxy-3,4,5,6,7,8-hexahydro-lH-quinolin-2-one
and 40 percent of the 3,4,4a,5,6,7-hexahydro isomer.
A mixture of 2-oxo-6-benzoyloxy-3,4,5,-
6,7,8-hexahydroquinoline and its ~8(8a) isomer obtained
from 6; g. of 4-benzoyloxycyclohexanone as above
without further purification was dissolved in a
mixture of 300 ml. of tetrahydrofuran (THF~ and
300 ml. of dimethylformamide. 14 g. of sodium hydride
were added, thus forming the sodium salt of the
quinoline. This mixture was stirred at ambient
temperature for about 20 minutes under a nitrogen
atmosphere after which time 55 g. of benzyl bromide in
75 ml. of THF were slowly added over a 10 minute
period. The reaction mixture was stirred for an
additional hour in the range 32-45C. and was then
diluted with water. The aqueous mixture was extracted
with etAyl acetate. The ethyl acetate extract was
separated, washed with water and with saturated
aqueous sodium chloride, and then dried. Evaporation
of the ethyl acetate yielded a mixture of l-benzyl-
2-oxo-6-benzoyloxy-3,4,5,6,7,8-hexahydroquinoline and
l-benzyl-2-oxo-6-benzoyloxy-3,4,4a,5,6,7-hexahydro-
,5 quinoline; yield = 106 g.
106 g. of the above mixture were dissolvedin 1 1. of THF and the solution cooled in an ice-
water bath. 40 q. of lithium aluminumhydride were
added thereto in portions. After the addition had
been compieted, the reaction mixture was heated to
~1334~
-23-
refluxing temperature under a nitrogen atmosphere for
about 4 hours. The react~on mixture was then cooled
and excess lithium aluminumhydride destroyed by the
addition of ethyl acetate. 10 percent aqueous sodium
hydroxide was added to decompose any organometallic
compounds present in the mixture. At this point, tAe
reaction mixture was diluted with water. The re-
sulting aqueous mixture was extracted several times
with chloroform. The chloroform extracts were separated
and combined. The combined extracts were washed with
saturated aqueous sodium chloride and then dried.
Evaporation of the chloroform yielded a residue
comprising a mixture of l-benzyl-6-hydroxy-1,2,3,4,5,-
6,7,8-octahydroquinoline and 1-benzyl-6-hydroxy-
1,2,3,4,4a,5,6,7-octahydroquinoline. (Both the 2-oxo
group and the 6-benzoyloxy group reacted with the
lithium aluminum hydride to yield an octahydroquino-
line with a free alcohol at C-6). The mixture of
compounds thus obtained was dissolved in ether, the
ethereal solution cooled, and gaseous anhydrous
hydrogen chloride passed into the solution, thus
forming the hydrochloride salts of the quinoline
isomers. The quinoline hydrochlorides were insoluble
and were separated by decantantation of the ether.
The residual salts were dissolved in 100 ml. of
methanol and 400 ml. of THF. The solution was cooled
and 30 g. of sodium cyanoborohydride added thereto in
po~tions. After the addition had been completed, the
cooling batn was removed and the reaction mixture
stirred at ambient temperature for 1.25 hours, after
11;~3~
-24-
which time it was poured into a mixture of lN aqueous
hydrochloric acid and ice. The acidic solution was
extracted with ether, and the ether extract discarded.
The acidic solution was then made basic with 10 percent
aqueous sodium hydroxide and the alkaline mixture
extracted several times with a chloroform-isopropanol
solvent mixture. The organic extracts were combined,
and the combined extracts washed with saturated
aqueous sodium chloride and then dried. Evaporation
of the solvent yielded trans-dl-1-benzyl-6-hydroxy-
decahydroquinoline formed in the above reaction; yield
= 53.6 g. Total yield in 6 steps was 73 percent based
upon recovered 4-benzoyloxycyclohexanone starting
material.
53 g. of trans-dl-1-benzyl-6-hydroxydeca-
hydroquinoline were dissolved in 1.5 l. of methylene
dichloride and the solution cooled in an ice-water
bath. 50 g. of cyanogen bromide were added and the
resulting mixture stirred at room temperature for 15
2C hours. The reaction mixture was washed successively
with lN aqueous hydrochloric acid and water, and was
then dried. Evaporation of the solvent yielded a
residue containing trans-dl-l-cyano-6-hydroxydeca-
hydroquinoline formed in the above reaction. The
residue was dissolved in chloroform and the chloroform
solution chromatographed over 300 g. cf~lFlorisil~lusing
chloroform containing increasing amounts (0-2%) of
methanol as the eluant. Fractions shown by TLC to
*Trademark for a highly selective adsorbent of hard
granular or powdered magnesium silicate, employed in
chromatography.
1~;33~7
-25-
contain the desired cyano compound were combined and
the solvent removed-from the combined fraction by
evaporation in vacuo. trans-dl-l-cyano-6-hydroxy-
decahydroquinoline thus prepared weighed 22.5 g.
22.5 g. of trans-dl-1-cyano-8-hydroxy-
decahydroquinoline were dissolved in 1200 ml. of
methylene dichloride. 33 g. of pyridine hydro-
chloride:chromium trioxide (Sarett's Reagent) were
added. The reaction mixture was stirred at room
temperature under nitrogen for about 6 hours, and was
then filtered. The filtrate was concentrated in vacuo
and the concentrate chromatographed over 300 g. of
"~orisil"using chloroform containing 1 percent methanol
as the eluant. Fractions shown by TLC to contain
trans-dl-1-cyano-6-oxodecahydroquinoline formed in the
above reaction were combined and the combined fractions
evaporated to dryness in vacuo. Recrystallization of
the resulting residue from an ether-chloroform solvent
mixture yielded trans-dl-l-cyano-6-oxodecahydroquinoline
20 melting at 86-8C.; yield = 18.9 g.
Analysis:Calculated: C, 67.39; H, 7.92; N, 15.72.
Found: C, 67.15; H, 7.75; N, 15.46.
17.6 g. of trans-dl-1-cyano-6-oxodecahydro-
quinoline were dissolved in 200 ml. of benzene to
which 100 g. of the dimethylace~al of dimethylformamide
had b~en ~dded. The reaction mixture was heated to
re'luxing temperature under nitrogen for about 20
hours and was then cooled. Evaporation of the solvent
in vacuo yielded a residue comprising trans-dl-l-
cyano-6-oxo-7-dimethylaminomethylenedecahydroquinoline
bTradem~
~133~
-26-
formed in the above reaction. The compound was
purified by chromatography over 300 g. of~lFlorisilll
using chloroform containing increasing amounts (0-2%)
of methanol as the eluant. 10.2 g. of trans-dl-l-
cyano-6-oxo-7-dimethylaminomethylenedecahydroquinoline
melting at 159-163C. were obtained. The compound was
crystallized from toluene to yield crystals melting at
162-4C.
Analyais:Calculated: C, 66.92; H, 8.21; N, 18.01.
Found: C, 67.14; H, 8.16; N, 18.04.
10.2 g. of trans-dl-1-cyano-6-oxo-7-
dimethylaminomethylenedecahydroquinoline were dis-
solved in 400 ml. of methanol. 2.8 g. of 85 percent
hydrazine were added and the subsequent reaction
lS mixture stirred for about 1 day under a nitrogen
atmosphere. The volatile constituents were then
removed by evaporation in vacuo. The residue was
dissolved in chloroform and the chloroform solution
chromatographed over 150 g. of"Florisil"using chloro-
form containing increasing ~mounts (2-5%) of methanol
as the eluant. Fractions shown by TLC to con~ain the
desired octahydropyrazoloquinoline were combined and
the solvent evaporated therefrom to dryness; yield =
6.3 g. Recrystallization of the residue from ethanol
yielded a mixture of trans-dl-5-cyano-4,4a,5,6,7,8,8a,9-
octahydro-2H-pyrazolo[3,4-g]quinoline and its lH
tautomer melting at 193-5C.
Analysis:Calcu'ated: C, 65.32; H, 6.98; N, 27.70
Found: C, 65.48; H, 6.80; N, 27.64
*Trademark
:11;33~
-27-
Example B
Preparation of trans-dl-4,4a,5,6,7,8,8a,9-Octahydro-
lH (and 2H)-pyrazolo[3,4-g]quinoline
A reaction mixture prepared from 860 mg of
trans-dl-S-cyano-4,4a,5,6,7,8,8a,9-octahydro-lH and
2H-pyrazolo[3,4-g]quinoline, (from Example A), S g.
of zinc dust, 10 ml. of water and 50 ml. of acetic
acid. The mixture was heated to refluxing temperature
under a nitrogen atmosphere for 18.5 hours after which
time it was filtered and the filtrate poured over ice.
The resulting aqueous mixture was then made basic with
14N ammonium hydroxide and the resulting alkaline
aqueous layer extracted several times with a chloro-
,5 form-isopropanol solvent mixture. The organic extracts
were combined and the combined extracts washed with
saturated aqueous sodium chloride and then dried.
Evaporation of the solvent yielded a residue com-
prising trans-dl-4,4a,5,6,7,8,8a,9-octahydro-2H-
pyrazolo[3,4-g]quinoline and the lH tautomer formed in
the above reaction. The residue was dissolved in
ethanol and 0.70 ml. of 12N aqueous hydrochloric acid
added thereto. The mixture of trans-dl-4,4a,5,6,7,8,8a,9-
octahydro-2H-pyrazolo[3,4-g]quinoline and the lH-
tautomer dihydrochlorides formed as above melted at284-7C.; yield = 780 mg.
Analysis:Calculated: C, 48.01; H, 6.85; N, 16.80.
Found: C, 48.07; H, 7.05; N, 16.83.
3~
113;~
-28-
Example C
Preparation of trans-dl-5-n-Propyl--7-ethoxycarbonyl-
4,4a,5,6,7,8,8a,9-octahydro-lH (and 2H)-pyrazolo~3,4-
g]quinoline
A mixture of 10 ml. of n-propyl amine and
400 ml. of toluene were cooled in an ice-water bath.
A solution of 16.5 g. of ethyl a-(bromomethyl)acrylate
in 50 ml. of toluene was added thereto in dropwise
fashion. The resulting mixture was stirred with
cooling for about 25 minutes. Next, a solution of
11 g. of 4-benzoyloxycyclohexanone in 75 ml. of
toluene was added in dropwise fashion. This new
mixt~re was heated under a nitrogen atmosphere to
refluxing temperature for about 23 hours. The reflux
condenser was equipped with a Soxhlet extractor
containing a 5A sieve to remove water. Next the
reaction mixture was cooled and the cooled mixture
filtered. Evaporation of the filtrate yielded a
residue comprising a mixture of 1-n-propyl-3-ethoxy-
carbonyl-6-benzoyloxy-1,2,3,4,5,6,7,8-octahydro-
quinoline and l-n-propyl-3-ethoxycarbonyl-6-benzoyioxy-
1,2,3,4,4a,5,6,7-octahydroquinoline. The residue was
dissolved in an ether-chloroform solvent mixture and
the resulting solution saturated witn gaseous hydrogen
chloride while maintaining the temperature in the
range 0-5C. The solvent was decanted from the
crystalline hydrochloride salts thus formed. The
salts were dissolved in 100 ml. of methanol. 300 ml.
3 o OI THF were added and the resulting solution cooled in
113~487
-29-
an ice-water bath. 15 g. of sodium cyanoborohydride
were added in portions to the stirred and cooled
reaction mixture. After the addition had been
completed, the reaction mixture was stirred for
another 1.25 hours after which time it was diluted
with aqueous sodium bicarbonate. The aqueous alkaline
mixture was extracted several times with ethyl
acetate. The ethyl acetate extracts were com~ined and
the combined extracts washed with saturated aqueous
sodium chloride solution and then dried. Evaporation
of the solvent yielded trans-dl-l-n-propyl-3-ethoxy-
carbonyl-6-benzoyloxydecahydroquinoline. The compound
was aissolved in a mixture of 400 ml. of methanol and
100 ml. of 2N aqueous sodium hydroxide. This mixture
l; was stirred at ambient temperature under a nitrogen
atmosphere for 64 hours after which time the volatile
constituents were removed by evaporation in vacuo.
The resulting residue was suspended in 800 ml. of
e~hanol and 15 ml. of 12N aqueous hydrochloric acid.
The esterification mixture was heated to refluxing
temperature and about 300 ml. of solvent removed by
distillation. 300 ml. of additional ethanol were
added and the reaction mixture heated to refluxing
temperature for 26 hours in an apparatus equipped with
a Soxhlet trap containing a 3A sieve. The reaction
mixture was cooled, diluted with aqueous sodium
bicarbonate and the alkaline mixture extracted several
times with chloroform. The chloroform extracts were
-ombined and the combined extracts washed with satu-
rated aqueous sodium chloride and then dried. Evapo-
1~3~ 7
-30-
ration of the chloroform yielded 10.3 g. of a residue
comprising trans-dl-l-n-propyl-3-ethoxycarbonyl-6-
hydroxydecahydroquinoline formed in the above hydrolysis
after chromatography over 150 g. of"~lorisil"using
chloroform containing increasing amounts (2-10%) of
methanol as the eluant.
A solution was prepared from 8.8 g. of
trans-dl-l-n-propyl-3-ethoxycarbonyl-6-hydroxydeca-
hydroquinoline and 400 ml. of methylene dichloride.
4.1 g. of sodium acetate were added. Next, 10.8 g. of
pyridine hydrochloride:chromium trioxide were added
and the resulting mixture stirred for about 22 hours.
The reaction mixture was filtered and the filtrate
concentrated in v~cuo. The resulting concentrate was
dissolved in chloroform and the chloroform solution
chromatographed over 150 g. of"Florisil"using chloro-
form containing increasins amounts (1-2%) of methanol
as the eluant. Fractions shown by thin-layer chroma-
iography tG contain trans-dl-l-n-prcpyl-3-ethoxycar-
2~ bonyl-6-oxodeca};ydroquinolir,e formed in the above
reaction we-e combined and the solven, removed from
the combined extr2cts to yield ~.48 g. of the 6-oxo
compound as a recidue. The 6-oxo compound was dis-
soived in 100 ml. of toluene containing an added
25 ml. cf the dimethylacetal of dimethylfc~amide.
The resulting mixture was heated to refluxing tem-
perature unaer 2 nitrogen atmosphere for 44 hours and
w~s then allowed to remain at room temperature for an
additional 4 days. Volatile constituents were removed
by evaporation in VaCUO and the residue, comprisir.g
- *Trademark
33~4
-31-
trans~dl~l~n~propyl-3~ethoxycarbonyl~6-oxo-7-~dimethylamino-
metfiylene)decahydroquinoline formed in the above reaction, was
purified by chromatographing a chloroform solution of the compound
over "Floris;~l"* using chloroform containing increasing amounts
~2-5%~ of methanol as the eluant. Fractions shown by TLC to con-
tain the desired 7-dimethylaminomethylene compound were combined
and the solvent evaporated therefrom in vacuo.
A solution was prepared from 2.24 g. of trans-dl-l-n-
propyl-3-ethoxycarbonyl-6-oxo-7-dimethylaminomethylene decahydro-
lQ ~quinoline and 150 ml. of ethanol. 0.45 ml. of hydrazind hydratewere added and the resulting mixture stirred at ambient tempera-
ture for about 17 hours. The reaction mixture was evaporated to
dryness in vacuo. The residue containing a mixture of trans-dl-
5~propyl-7-ethoxycarbonyl-4,4a,5,6,7,8,8a,9-octahydro-2H-pyrazolo-
~3,4-g~ quinoline and trans-dl-5-n-propyl-7-ethoxycarbonyl-4,4a,-
5,6,7,8,8a,9-octahydro-lH-pyrazolo[3,4-g~quinoline was dissolved
in chloroform and the resulting solution chromatographed over 35
g. of "Florisil"* using chloroform containing 2 percent methanol
as an eluant. Fractions shown to contain the desired pyrazolo-
quinoline by TLC were combined and the solvent evaporated there-
from in vacuo. Recrystallization from a mixture of ether and
hexane yielded trans-dl-5-n-propyl-7-ethoxycarbonyl-4,4a,5,6,7,-
8,8a,9-octahydro-2H-pyrazolo~3,4-~ quinoline and its lH tautomer
melting at 125-7C.
Analysis:Calculated: C, 65.95; H, 8.65; N, 14.42.
Found: C, 65.75; H, 8.42; N, 14.16.
*Trademark
1133~
-32-
Example D
Preparation of trans dl-5-n-~ropyl-7-hydroxymethyl-4,4a,5,6,7,-
8,8a,g-octahydro--lH tand 2H~-pyrazolo~3,4-g~quinoline
A mi~ture of trans-dl-5-n-propyl-7-ethoxycarbonyl-4,4a,
5,6,7,8,8a,9-octahydro-2H-pyrazolo ~,4-g~ quinoline dihydrochloride
and the dihydrochloride salt of the lH tautomer (3.7 millimoles)
(prepared in Example C) was suspended in 200 ml. of THF. 1 g. of
lithium aluminumhydride was added thereto in portions. The con-
sequent reaction mixture was stirred at ambient temperature under
lQ a nitrogen atmosphere for about 16 hours, and was then cooled.
Ethyl acetate and 10 percent aqueous sodium hydroxide were added
thereto seriatim to react with any excess lithium aluminumhydride
and to decompose organometallic compounds present. The reaction
mixture so treated was then diluted with water and the aqueous
mixture extracted several times with a chloroform-isopropanol
solvent mixture. The organic layers were separated and combined.
The combined layers were washed with saturated aqueous sodium
chloride and then dried. Evaporation of the solvent yielded a
mixture of trans-dl-5-n-propyl-7-hydroxymethyl-4,4a,5,6,7,8,8a,9-
2Q octahydro-2H-pyrazolo~3,4-~ quinoline and its lH tautomer. The
residue was dissolved in ethanol to which was added 0.2 ml. of
12N aqueous hydrochloric acid. Evaporation of the volatile con-
stituents yielded a residue comprising trans-dl-5-n-propyl-
~1334~3~
-33-
7-hydroxymethyl-4,4a,5,6,7,8,8a,9-octahydro-2H and
lH-pyrazolo[3,4-g]quinoline dihydrochlorides. The
residue was dissolved in a mixture of methanol and
acetone to yield crystals melting at 270-5C. with
5 decomposition; yield = 350 mg.
The above reaction was repeated with 1.55 g.
of trans-dl-5-n-propyl-7-ethoxycarbonyl-4,4a,5,6,7,-
8,8a,9-octahydro-2H-pyrazolo[3,4-g]quinoline in THF
being reduced with an excess of lithium aluminum-
hydride. The product of the reaction, trans-dl-5-
n-propyl-7-hydroxymethyl-4,4a,5,6,7,8,8a,9-octahydro-
lH and 2H-pyrazolo[3,4-g]quinoline, was crystallized
from a mixture of chloroform and ethanol to yield
crystalline material melting at 167-9C.
l; Analysis:Calculated: C, 67.43; H, 9.30; N, 16.85;
Found: C, 67.21; H, 9.13; N, 16.62.
Example E
Alternate Preparation of l-n-Propyl-6-benzoyloxy-
3,4,5,6,7,8-hexahydro-2(1H)-quinDlinone and 1-
n-Propyl-6-benzoyloxy-3,4,4a,5,6,7-hexahydro-2(1H)-
quinolinone
A reaction mixture was prepared containing
4.4 g. of 4-benzoyloxycyclohexanone lprepared by the
procedure of E. R. H. Jones and F. Sondheimer, J.
Chem. Soc., 615 (1949)], Z.5 ml. of n-propylamine
and 100 ml. toluene. The mixture was heated to
reflux temperature for about 2 hours under a nitro-
gen atmosphere using a Dean-Stark water trap. The
reaction mixture was then heated to r~fluxing
1~3~
-34-
temperature for an addltional 2 hours in the presence
of a molecular sieve to remove water. The reaction
mixture was cooled and the solvent removed by
evaporation in vacuo. 4 ml. of methyl acrylate and
100 ml. of dioxane were added to the residue and the
resulting mixture was refluxed overnight under a
nitrogen atmosphere. The reaction mixture was again
cooled and the volatile constituents removed by
evaporation in vacuo. Chromatography of an ethereal
solution of the resulting residue over 200 g. or
"~lorisil"using ether as an eluant yielded a mixture
of l-n-propyl-6-benzoyloxy-3,4,5,6,7,8-hexahydro-
2(lH)-quinolinone and l-n-propyl-6-benzoyloxy-
3,4,4a,5,6,7-hexahyd-o-2(1H)-quinolinone: yield =
2.1~ g.
FINAL PRODUCTS
Example 1
Preparaticn of trans-dl-5-r-~ropyl-4,4a,5,6,7,8,-
2G 8a,9-octahydro-1~. ~ar.d 7~) -pyrazolo[3,4-g]quinoline
A reaction mixture was prepared from
6.3 g. of a mix'ure of trans-al-5-cvano-4,4a,5,6,-
7,8,8a,9-octahydro-2H-pyrazolo~3,4-g]quinoline and
its lH-tzutomer (prepared by the procedure of
~xa~ple .~, 30 g. cf zinc dust, 375 ml. of acetic acid
a~d ~5 ml. Oc water. The reaction mixture was heated
to refluxing temperature under nitrogen for 16 hours
after which time it was filtered and the filtrate
*Trademark for a highly selective adsorbentof hard
granular or powdered magnesium silicate.
113~34~7
-35-
poured over ice. The resulting aqueous mixture was
made basic by the additon of 14N aqueous ammonium
hydroxide and the alkaline layer extracted several
times with a chloroform-isopropanol solvent mixture.
The organic extracts were combined, the combined
extracts washed with saturated aqueous sodium chlorid~
and then dried. Evaporation of the solvent yielded a
residue comprising trans-dl-4,4a,5,6,7,8,8a,9-
octahydro-2H-pyrazolo[3,4-g]quinoline and its lH-
tautomer formed in the above reaction. The residuewas dissolved in 500 ml. of methanoi to which was
added l.9 g. of sodium cyanoborohydride. ~ext 20 ml.
of propionaldehyde were added and the resulting
mixture stirred at ambient te~perature under a nitrogen
atmosphere for 28 hours. The reaction mixture was
then poured into lN aqueous hydrochloric acid. The
aqueous layer was extracted with ether and the ether
extr-cts discarded. The aqueous layer was then maae
basic by the addition of an excess of 14N aqueous
ammonium hydroxide and the resulting alkaline layer
extracted several times with a chloroform-isopropanol
solvent mixture. The organic extracts were co~ined
and the combined extracts washed with saturated
aqueous sodium chloride and tben dried. Evaporation
of the solvent yielded a residue comprising trans-
dl-5-n-propyl-4,4a,5,6,7,B,8a,9-octahydro-lH and
2~-pyrazolo~3,4-~]quinoline formed in the above
reaction. ~ass spectru~: M = 213.
The residue was dissolved ln 100 ml. of
boiling acetGne to which were added 5 ml. Or 12N
~11;3;~1t ~r~
-36-
aqueous hydrochloric acid in dropwise fashion. The
mixture was cooled and the dihydrochlorides of trans-
dl-5-n-propyl-4,4a,5,6,7,8,8a,9-octahydro-lH and 2H-
pyrazolo[3,4-g]quinoline thus formed separated by
5 filtration; yield = 4.6 g.; m.p. = 250-7C.
Analysls:Calculated: C, 53.43; H, 7.93; N, 14.38
Cl, 24.26.
Found: C, 53.15; H, 7.91; N, 14.47;
Cl, 24.33.
Example 2
Preparation of trans-dl-5-n-Propyl-4,4a,5,6,7,8,8a,9-
octahydro-lH (and 2H)-pyrazolo[3,4-g~quinoli~e
Using the procedure of Example 1, 1.2 g. of
a mixture of trans-dl-5-cyano-4,4a,5,6,7,8,8a,9-
octahydro-2~-pyrazolo[3,4-g]quinoline and its mixture
of l~-tautomer were reacted with zinc dust and acetic
acid to form a mixture of trans-dl-4,4a,5,6,7,8,~a,9-
octahydro-2H-pyrazolo[3,4-g]quinoline and its lH
tautomer which was isolated as a residue. This
reidue dissolved in 50 ml. cf DMF to which were added
1.7 g. of potassium carbona~e. Next, 0.6 ml. of
n-propyl iodide were added and the resulting mixture
stirred at ambient temperature for about ~ hours under
a nitrogen atmosphere. The reaction mixture was
dilute~d with water and the resulting aqueous mixture
extr~cted several times with ethyl acetate. The ethyl
acetate extracts were combined and the combined
extracts washed successively with water an~ saturated
aqueous sodium chloride and were then dried. Evapo-
1133~
ration of the ethyl acetate yielded a residue comprising trans-
dl-5~n~propyl~4,4a,5,6,7,8,8a,9-octahydro-2H-pyrazolo~3,4-g7-
quinoline and its lH tautomer which was purified by chromatography
over 30 g. of "Florisil"* using chloroform containing increasing
amounts ('2-10%~ of methanol as the eluant. Fractions shown by
TLC to contain trans-dl-5-n-propyl-4,4a,5,6,7,8,8a,9-octahydro-
2H and lH-pyrazolo[3,4-g~quinoline were combined and the combined
extracts evaporated to dryness to yield 0.28 g. of trans-dl-5-
n-propyl-4,4a,5,6,7,8,8a,9-octahydro-2H-pyrazoloC3,4-g~quinoline
and its lH tautomers. The residue was dissolved in ethanol to
which was added Q.16 ml. of 12N aqueous hydrochloric acid, thus
forming the dihydrochlorides of trans-dl-5-n-propyl-4,4a,5,6,7,
8,8a,9-octahydro-2H-pyrazolo~3,4-~ quinoline and the lH tautomer.
The reaction mixture was concentrated in vacuo and the concen-
trate diluted with ether. A mixture of trans-dl-5-n-propyl-4,4a,-
5,6,7,8,8a,9-octah,ydro-lH and 2H-pyrazolo~3,4-~ quinoline di-
hydrochloride crystallized and was separated by filtration; m.p.
= 276-8C.
Example 3
Preparation of trans-dl-5-n-Propyl-7-methylmercaptomethyl-4,4a,
5,6,7,8,8a,9-octahydro-lH (and 2H)-pyrazolo C3,4-g]quinoline
A suspension was prepared from 1 millimole of trans-dl-
5 n~propyl-7-hydroxymethyl-4,4a,5,6,7,8,8a,9-octahydro-lH and
2H-pyrazolo~3,4-g~ quinoline
*Trademark for a highly selective adsorbent of hard
granular or powdered magnesium silicate.
1:13~
-38-
in lQO ml. of pyridine~ 1 ml~ of methanesulfonyl chloride (mesyl
cfiloride) was added and the resulting mixture left over night at
amfiient temperature. The mixture was diluted with dilute aqueous
ammonium hydroxide and the resulting alkaline layer extracted
several times with chloroform. The chloroform extracts were com-
bined and the combined extracts washed with saturated aqueous
sodium chloride and then dried. Evaporation of the solvent
yielded a solid residue. A chloroform solution of the residue
was chromotographed over 30 g. of "Florisil"* using chloroform
containing increasing amounts (1-2%~ of methanol as the eluant.
Fractions shown by TLC to contain trans-dl-2-methanesulfonyl-5-
n-propyl-7-mesyloxymethyl-4,4a,5,6,7,8,8a,9-octahydro-2H-
pyrazolo ~,4-~ quinoline were combined and the solvent was removed
therefrom ~y evaporation. trans-dl-2-Methanesulfonyl-5-n-propyl-
7 mesyloxymethyl-4,4a,5,6,7,8,8a,2-octahydro-2H-pyrazolo r3,4-
quinoline melted 152-4C. after recrystallization from ether.
Analysis:Calculated: C, 47.39; H, 6.71; N, 10.36;
S, 15.81.
Found: C, 47.60; H, 6.71; N, 10.32;
S, 15.69.
A second fraction was obtained from the chromatography
was shown by NMR to be a 2:1 mixture of trans-dl-5-n-propyl-7-
mesyloxymethyl-2-methanesulfonyl-4,4a,5,6,7,8,8a,9-octahydro-2H-
pyrazoloC3,4-~ quinoline and its l-methanesulfonyl-lH isomer.
*Trademark
113~
-39-
1 g. of methylmercaptan was dissolved in
40 ml. of dimethylformamide. The solution was cooled
in an ice-water bath. About 1 g. of sodium hydride
(as a 50% suspension in mineral oil) was added thereto
in portions. The cooling bath was removed and a
solution containing 0.4 g. of trans-dl-2-methane-
sulfonyl-5-n-propyl-7-mesyloxymethyl-4,4a,5,6,7,8,8a,9-
octahydro-2H-pyrazolo[3,4-g]quinoline containing some
trans-dl-l-methanesulfonyl-5-n-propyl-7-mesyloxy-
10 methyl-4,4a,5,6,7,8,8a,9-octahydro-lH-pyrazolo[5,4-
g]quinoline in 10 ml. of DMF prepared above was
added. The reaction mixture was stirred at am~ient
temperature for about 5 hours and was then diluted
with water. The aqueous mixture was extracted several
times with ethyl acetate. The ethyl acetate extracts
were separated and combined. The combined extracts
were washed with water and with saturated aqueous
sodium chloride and then dried. Evaporation of the
solvent yielded an oily residue comprising trans-
20 dl-5-n-propyl-7-methylmercaptomethyl-4,4a,5,6,7,8,8a,9-
octahydro-lH and 2H-pyrazolot3,4-g]quinoline; yield =
0.17 g~ The residue was dissolved in ethanol and
attempts made to prepare both the hydrochloride and
the oxalate salts. Both salts initially t~1rned out to
be noncrystalline. The free bases were then recovered
from the non-crystalline oxalate by dissolving the
oxalate in water, adding base and ex'rac_ing the
mixture witn ether. trans-dl-5-n-Propyl-?-methyl-
30 mercaptomethyl-4,4a,5,6,7,8,8a,9-octahydro-lH and
~13;~4~
-40-
2H-pyrazolo[3,4-g]quinoline thus purified crystallized
on evaporation of the ether; melting point = 175-7C.;
yield = 40 mg.
Analysis:Calculated: C, 64.47; H, 9.02; N, 15.04;
S, 11.47.
Found: C, 64.47; H, 8.96; N, 15.09;
S, 11.29.
The above purified free base tautomeric
mixture was dissolved in ethanol and an excess of
12N hydrochloric acid added. The volatile con-
stituents were removed by evaporation and the
resulting residue comprising the corresponding
dihydrochloride salts crystallized from an acetone-
methanol solvent mixture.
;5 Analysis:Calculated: C, 51.13; Y, 7.72; N, 11,93;
Cl, 20.10; S, 9.10;
Found: C, 50.89; H, ?.57; N, 12.15;
Cl, 20.18; S, 9.31.
Example 4
Preparation of trans-dl-5-Methyl-4,4z,5,6,7,8,8a,9-
octahydro-lH (and 2H)-pyrazolo[3,4-g]quinoline
46.5 g. of the isomer mixture containing
about 60 percent of 6-benzoyloxy-3,4,5,6,7,8-
hexahydro-lH-quinoline-2-one and 40~ of the 3,4,4a,-
5,6,7-hexahydro isomer were dissolved in 400 ml. of
tetrahydrofuran (THF). 80 ml. of methyl iodide were
added and the resulting mixture cooled in an ice-
water bath. 9.6 g. of sodj.u~ hydride (as a 50
percent sus~ension in mineral o 1) we.e added in
11334~
-41-
portions. After all of tne sodium hydride sus-
pension had been added, the cooling bath was removed
and the reaction mixture stirred at ambient tem-
perature under a nitrogen atmosphere for about 4
hours. The reaction mixture was then diluted with
water and the aqueous m xture thoroughly extracted
with chloroform. The chloroform extracts were
combined and the combined extracts washed with
saturated aqueous sodium chloride and then dried.
The chloroform was removed by evaporation to dryness
in vacuo leaving as a residue an orange oil weighing
47.3 g. Crystallization of the residue from an
ether-hexane solvent mixture yielded crystals of 1-
methyl-6-benzoyloxy-3,4,5,6,7,8-hexahydro-2(1H)-
~uinolinone and the corresponding 3,4,4a,5,6,7-
hexahydro isomer.
Analysis:Calculated: C, 71.56; H, 6.71; N, 4.91.
Found: C, 71 33; ~., 6.90; N, 4.67.
A solution of 47.3 g. of a mixture of 1-
2C mzthyl-6-benzoyloxy-3,4,5,6,7,8-hexahydro-2;1~)-
quinolinone and the corresponding 3,4,4a,5,6,7-
hexahydro isomer as obtzined above were dissolved in
800 ml. of THF and the solution cooled to about 0C.
20 g. of iithium aluminumhydride were added thereto
in portior.s and the resultlng mixture refluxed for
four hours under a nitrogen atmosphere. The reaction
mixture was cooled and excess lithium aluminum-
hydrice destroyed by the addition of ethyl acetate.
10~ sodiur, hydrcxide was then added and the mixture
diluted with water to decompose any orsanometal'ics
~133~8'7
-42-
present. The aqueous mixture was extracted several
times with a chloroform-isopropanoi solvent mixture.
The organic extracts were combined and the combined
extracts washed with saturated aqueous sodium
chloride and then dried. Evaporation of the solvent
yielded as a residue a mixture of the enamines--
l-methyl-6-hydroxy-1,2,3,4,5,6,7,8-octahydroquinoline
and l-methyl-6-hydroxy-1,2,3,4,4a,5,6,7-octahydro-
quinoline-- formed in the above reaction. (The
lithium aluminumhydride reduction served to remove
the benzoyl group at C-6 as a benzyl alcohol moiety,
leaving a,free hydroxyl in that position). The
above residue, without further purification, was
dissolved in about 300 ml. of ether and the ethereal
solution saturated with gaseous hydrogen chloride,
thus forming the hydrochloride salt of the enamine
mixture. The e~her was removed by decantaticn and
the residue dissolved in a mixture of 200 ml. of T~
and S0 ml. of methanol. This solution was cooled in
an ice-water bath. 12 g. of sodium cyar.oborohydride
were added with cooling and stirrins. After all of
the cyanoborohydride had been added, the reaction
mixture was stirred for another 60 minutes and then
poured over a mixture of ice and lN aqueous hydro-
chloric acid. The acidic aqueous solutior, wasexLracted with chloroform and the chloroform extract
discardad. The sclut-on was then made basic with
14N aqueous ammonium hydroxide. T.ans-dl-l-methyl-
6-hydroxydecahydroquinoline for~ed in the above
reaction, being insoluble in the alkaline medium,
~1~3;3a~8~7
-43-
separated and was extracted several times with a
chloroform-isopropanol solvent mixture. The
combined extracts were washed with saturated aqueous
sodium chloride and then dried. Evaporation of the
solvent yielded 15 g. of trans-dl-1-methyl-6-
hydroxydecahydroquinoline.
Fifteen grams of trans-dl-l-methyl-
6-hydroxydecahydroquinoline were dissolved in
250 ml. of 6N aqueous sulfuric acid. The solution
was cooled in an ice-water bath. A solution of 9 g.
of chromium trioxide in 60 ml. of 6N aqueous sul-
furic acid were added thereto with stirring in
dropwise fashion over a 10-minute period. The
cooling bath was removed and the reaction mixture
stirred for an additional 60 minutes at ambient
temperature. The excess oxidizing agent was decom-
posed by adding isopropanol to the reaction mixture.
The reaction mixture was next poured over ice and
the acidic aqueous solution made basic with 14N
aqueous ammonium hydroxide. trans-dl-l-Methyl-
6-oxodecahydroquinoline thus formed, being insoluble
in the alkaline layer, separated and was extracted
several times with a mixture of chloroform and
isopropanol. The extracts were combined and the
combined extracts washed with saturated aqueous
sodium chloride and then dried. Evaporation of the
solvert in vacuo yielded trans-dl-l-methyl-6-
oxodecahydroquinoline boiling in the range 105-116C.
a, 6 torr; yield = 7.7 g. (45%).
1~334t3 ~'
-44-
A reaction mixture was prepared frGm
7.7 g. of trans-dl-1-methyl-6-oxodecahydroquinoline,
36 g. of the dimethyl acetal of dimethylformamide
and 250 ml. of benzene. Benzene was removed by
distillation at atmospheric pressure under nitrogen
until about 1/2 the original volume remained (1.25
hours). Sufficient benzene was then added to make
up the volume to the original volume and the process
was repeated (four times). All of the benzene was
finally removed by evaporation in vacuo and the
resulting residue dissolved in 100 g. of dimethyl-
formamide dimethylacetal. This solution was heated
to refluxing temperature under nitrogen for 20
hours. The reaction mixture was then e~aporated in
vacuo and a chloroform solution of the residue
chromatographed o~er 150 g. of"Florisil"using as the
eluant, methylene dichloride containing increasing
amounts ~1-5~) of methanol. Fractions containing
similar substances as shown by TLC were combined.
The tnird substance to be eluted was a yellow so;id
(wt = 3 g.) The solid was heated with 100 ml. of
e'her and 'he resulting solution filtered. Cor.-
cer,tration of the f~ltrate to about 50 ml. yielded
590 mg. of crystals of trans-dl-1-methyl-6-oxo-7-
dlmethylaminometh~lenedecahydroquinoline meltin~ at;07-109C.
Analy~is:Calculated: C, 70.23; H, 9.9,; ~i, 12.60.
Found: C, 70.17; H, 9.7~ 2.81.
*Trademark
1~33~
-4;-
A solution was prepared by dissolving
175 mg. of trans-dl-1-methyl-6-oxo-7-dimethylamino-
methylenedecahydroquinoline in 10 ml. of methanol.
0.05 ml. of hydrazine hydrate were added and the
resulting reaction mixture stirred at room tempera-
ture under a nitrogen atmosphere for 4.5 days. The
volatile constituents were removed by evaporation.
A chloroform solution of the residue was chromato-
graphed over 25 g. of"Florisil"using chloroform
containing increasing amounts (2-15%) of methanol as
the eluant. Fractions shown by TLC to contain a
substance moving close to the origin and different
than starting materi~l were combineZ and the solvent
removed from the co~bined fractions by eva_oration.
trans-a'-S-methyl-4,4a,5,6,7,8,8a,9-oct2hydro-lH-
~and 2H)-pyrazolo[3,4-g]quinoline free base gave a
molecular ion (~,+) at 191 by mass spectroscopy.
The re~ulting residue was disso~/ed in
ethano; and 2 ~1. of lN hydrochloric acid were
2C added. The acidic solution was evaporated to
dryness. Crystallization of the residue from
ethanol yielded a tautDmeric m~x.u_2 containins
trans-dl-S-methyl-4,4a,5,6,7,8,8a,9-octahydro-1~-
(and 2H)-pyrazolo[3,4-g~quinolin~ dinydroch~orides
melting at 268-70C. with decomposit_cr.; yi21d =
'40 mg.
~nalysis:Calculated: C, 5D.01; H, 7.25; ~, 15.9C;
C1, ~6.84.
Found: C, 49.~2 H, 7.08; N, 15.66i
Cl, 26.~0.
*Trademark
~13~r~
-46-
Example 5
Preparation of trans-dl-5-Allyl-4,4a,5,6,7,8,8a,9-
octahydro-lH(and 2H)-pyrazolo[3,4-g]quinoline
Following the procedure of Example A,
65 g. of 4-benzoyloxycyclohexanone, 38 ml. of
pyrrolidine and a few crystals of p-toluenesulfonic
acid monohydrate were dissolved in 1000 ml. of
cyclohexane. The resulting mixture was heated to
reflux in a nitrogen atmosphere using a Dean-Star~
water trap for about 1/2 hour. The mixture was then
cooled and the solvents removed by evaporation ln
vacuo. The residue, comprising the pyrrolidine
enamine of 4-benzoyloxycyclohexanone, was mixed with
53 g. of acrylamide in 1000 ml. of dioxane. The
reaction mixture was heated to reflux temperature in
a nitrogen atmosphere for about one day after which
time it was cooled and the volatile constituents
removed by evaporation. The resulting residue was
diluted with water and the aqueous mixture extracted
with ethyl acetate. The ethyl acetate extract was
separated, washed with water and with saturated
aqueous sodiu~ chloride and then d-ied. Evap-
oration of the solvent yielded a mixture of 6-
benzoyloxy-3,4,5,6,7,8-hexahydro-lH-quinoline-2-
one and the corresponding 3,4,4a,5,6,7,-hexahydro
compound.
The above mixture was dissolved in a
combination of 250 ml. of tetrahyrofuran and 250 ml.
of dimethylformamide. 12 q. of sodium hydride as a
50% suspension in mineral oil was added and the
113;~
-47-
mixture stirred in order to completely form the
sodium salt of the quinoline-2-one. Next 30 g. of
allyl brcmide as a solution in 75 ml. of THF were
added and the resulting mixture stirred for 24
hours. The temperature of the reaction mixture rose
rapidly and external cool~ng was supplied. After
the reaction had been completed, the reaction mixture
was diluted with water and the aqueous mixture
extracted with ethyl acetate. The ethyl acetate
extract was separated, washed with water and with
saturated aqueous sodium chloride and then dried.
Evaporation of the solvent yielded a mixture of
l-allyl-6-benzoyloxy-3,4,5,6,7,8-hexahydro-lH-
quinoline-2-one and the corresponding 3,4,4a,5,-
6,7-hexahydro compound.
The N-allyl derivative thus prepared was
dissolved in 750 ml. of THF and the solution cooled
in an ice-water bath. 20 g. of lithium aluminum
hydride were added thereto in portions. Afte- the
~0 addition had been completed, the resulting mixture
wafi heated to reflux temperature under a nitrogen
atmosphere for about three hours. The reaction
mixture was then cooled in an ice-water bath and the
excess lithium aluminum hydride decomposed by the
addition of ethyl acetate. 10~ aqueous sodium
hydroxide was added to decompose any organometallic
compounds present and the mixture thus treated was
diluted with water~ The aqueous mixture was then
extracted several times with chloroform and the
chloroform extracts combined. The combined extracts
t'~
-48-
were washed with saturated aquecus sodium chloride
and dried. Evaporation of the solvent yielded a
residue comprising a mixture of l-allyl-6-hydroxy-
1,2,3,4,5,6,7,8-octahydroquinoline and its 1,2,3,4,-
4a,5,6,7-octahydro isomer. The residue was dissolved
in 750 ml. of ether and the ethereal solution sat~rated
with anhydrous gaseous hydrogen chloride. The
hydrochloride salt of the octahydroquinoline
mixture, being insoluble in ether, precipitated and
the ether was separated by decantation. The hydro-
chloride was dissolved in a mixture of 100 ml. of
methanol and 300 ml. of THF. This solution was
cooled in an ice-water bath. 20 g. of sodium cyano-
borohydride were added thereto in portions while the
reaction mixture waC being cooled. After the addi-
tion had been completed, the cooling bath was .emoved.
The reaction was stirred at ambient temperature for
about 1 hour, and was then diluted with saturated
aqueous sodium bicarbonate. The alkaline layer was
extracted several times with chloroform. The chloro-
form extracts were combined and the combined extracts
washed with saturated aqueous sodium chloride and
then dried. Evaporation of the solvent yielded
about 12.8 g. of trans-dl-1-allyl-6-hydroxydeca-
hydroquinoline.
The trans-dl-l-allyl-6-hydroxy-deca-
hydroquinoline thus prepared was dissolved in
500 ml. of methylene dichloride to which had been
added 8.2 g. of sodi~m acetate. Next 21.6 g. of
pyridir.e hydrochloride/chrom~um trioxide were added.
1~3~ 7
_49-
The react~on was stirred for 7,5 hours under a nitrogen atmos-
pfiere at amb-~ent temperature, and was then filtered. The fil-
trate was concentrated in vacuo. Chromatography of the filtrate
over 150 g. of "Florisil"~ using chloroform containing increasing
amounts C1-5%~ methanol as the eluant yielded 3.2 g. of trans-dl-
allyl-6-oxodecahydroquinoline formed in the above reaction. The
6-oxo compound was dissolved in toluene and 25 ml. of dimethyl-
lormamide dimethylacetal were added. The reaction mixture was
heated to reflux temperature under a nitrogen atmosphere for 24
lQ hours after which time it was cooled and the solvent removed by
evaporation. The resulting residue was chromatographed over lS0
g. of "Florisil"* using chloroform containing increasing amounts
C2~20%) of methanol as the eluant. Fractions shown by TLC to
contain the desired trans-dl-l-allyl-6-oxo-7-dimethylaminomethy-
lenedecahydroquinoline formed in the above reaction were combinedto yield after evaporation of the solvent 1.3 g. of the desired
product. This material was dissolved in 75 ml. of methanol to
which was added 0.5 ml. of hydrazine hydrate. The reaction mix-
ture was stirred at room temperature for about 20 hours after
2Q which time the volatile constituents were removed by evaporation
in vacuo. A chloroform solution of the residue was chromato-
graphed over 35 g. of "Florisil"* using chloroform containing in-
creasing amounts (2-4~) of methanol as the eluant. Fractions
shown by TLC to contain the desired
*Trademark
113;~
-50-
trans-dl-5-allyl-4,4a,5,6,7,8,8a,9-octahydro-
2H-pyrazolo[3,4-g]quinoline and its lH tautomer were
combined and the solvent removed therefrom by
evaporation in vacuo. Mass spectrosccpy of the
residue gave a molecular ion at 217. The residue,
weighing 0.55 g., was dissolved in 75 ml. of acetone
and the acetone solution heated to reflux. 0.5 ml.
of 12N aqueous hydrochloric acid were added thereto
in dropwise fashion. The reaction mixture was
allowed tc cool. Trans-dl-5-allyl-4,4a,5,6,7,-
8,8a,9-octahydro-2H(and l~)-pyrazolo[3,4-g]quinoline
dihydrochloride thus prepared melted at about 215C.
with decomposition; weight = 495 mg.
Analysis calculated: C, 53.80; H, 7.29; N, 1.48;
Cl, 24.43
Found: C, 53.52; H, 7.1'; N, 1.65;
Cl, 24.17.
As evidence of the utility cf the compounds
of formulae Ia and Ib, it has been found that they
affect turning behavior in 6-hydroxydopamine-lesioned
rats in a test procedure designed to uncover compounds
useful for the treatment of Parkinsonism. In this
test, nigroneostriatal-lesioned rats are employed, as
~repared by the procedure of Ungerstedt and ~r~uthnGtt,
Brain Res, 24, 485 (1970). A compound having dopamine
gonist acti~ity causes the rats to turn in circles
contralateral to the side of the lesion. After a
latency period, which varies from compound to com-
pound, the number of turns is ccur.ted over a i5-
3C minute period.
~1331~8~
-51-
Results obtained from testing representative
compounds of formulae Ia and Ib in the rat turning
test are set forth in Table 1 below. The compounds
were dissolved in water and the aqueous solution
injected into the rat by the intraperitoneal route at
dose levels of 1 mg/kg. and 100 mcg/kg. In the table,
column 1 gives the name of the compound, column 2,
percent of test animals exhibiting tllrnlng behavior,
and column 3, average number of turns observed in
first 15 minutes after end of latency period.
1133~
--52--
,Y
~ o
V'
U
o ~ o
s~ o
_~
:~ 6 ~ .
Z E~ Y u~ .
. O
C~
E
.
~ l
g L'~ o
E ~-- m
~o ~
_~ ~ ~ ~ o
~ ~1 ~O o
Cl ~ ~ C:-r! _~
_~ .~I-rl ~
.a
~ Or~
E~ S :~ a) ~
dP X E~ ~ ~ o
;~ ~ o ,~
_l C~
.1
_I I I ~-~1
O `
~r I ~ S I ,1 ` ,1
~r ~1 ~ 1~ 1 ~ ~ o ~r _I o
~:: ~ ~ O ~S~r o -.-
~ :~S ` ~S I O
O Q~tO~ 0~--I O--1
D~ O ~-- O a~ ~ o
6 I I O O ~ h 6
O P~ O ~ J~ O co ~
I I 0 ~ S
C a' N ~-1C O~CO ~-rl I C~
~; I ` n~ o I ~ o ~1 ~
O U'~ 1 L'~ O
I CO ~SI Sl ` S C) ~ O _~
~ ~ u ~ D ~ C ~i s
E ~ c~ I o ~ 6 ` ~ O
~G I ` S ~I _I L' ~ ~ 0 C:~ N O
zl ~r~ 0 ~ ~c o C~
c ~ ~ c s ~ ~ e a c~
'O ~ C
l~;~ë'
--53--
The compounds of formulae Ia and Ib are
also useful as prolactin inhibitors and as such they
can be employed in the treatment of inappropriate
lactation such as postpartum lactation and galac-
5 torrhea. As evidence of their utility in the treat-
ment of conditions in which it is desirable to reduce
the prolactin level, the compounds of formulae Ia
and Ib have been shown to inhibit prolactin according
to the following procedure.
Adult male rats of the Sprague-Dawley
str2in weighing about 200 g. were housed in an air-
ccnditioned room with controlled lighting (lights on 6
a.m. - 8 p.m.) and fed ~ab chow and water ad libitum.
Each rat received an intraperitoneal injection of
2.0 mg. cf reserpine in aqueous suspension 18 hours
befGre administration Oc the test drug. The purpose
of the reserpine was to keep prolactin levels uni-
formly eievated. The compounds under test were
dissoived in 10 percent ethanol, and were injected
intraperltoneally at doses of 50 mcg/kg and 0. 5 and 5
mg/kg. Each compound was administered at each dose
level to a grGup of 10 rats, and a control group of 10
lntact males received an equivalent amount of 10
percent etnanol. One hour after treatment, all rats
were killed by decapitation, and 150 ~1 aliquots of
serum were assayed for prolactin.
The difference between the prolactin level
of the treated rats and prolactin level of the control
rats, divided by tne prola_tin level Oc the control
~0
11;~3~7
rats gives the percent inhibition of prolactin
secretion attributable to the compounds of formulae
Ia and Ib. These inhibition percentages are given in
Table 2 below. In the table, column 1 gives the name
of the compound; and columns 2, 3 and 4, the percent
prolactin inhibition at 50 mcg./kg, and O.S and
5 mg./kg. dose levels.
3~
--55--
~1 ~
o 1
C
U~
o ~J
J
r ~ ~
~ o
C
~ O ~
c E
o o
~
_ ~ o
C ' ~ 0 N
C~ I~ ~
~ ~ c `--cE ~D p,
''I ' ' ' ~ ~ - ~
E ¦ a ~ N ~ il~ ~C N ~11~ S
~ D ~ ~ ~-- ~ ~ ~ O--
. 1133~
-56-
In using the compounds of formulae Ia
and Ib to inhibit prolactin secretion or to treat
Parkinson's syndrome or for other pharmacologic
action, a compound according to formula Ia or Ib
above or a salt thereof with a pharmaceutically-
acceptable acid, is administered to a subject suf-
fering from Parkinsonism or in need of having his or
her prolactin level reduced in an amount effective to
treat Parkinsonism or to reduce prolactin. Oral
administration is preferred. If parenteral adminis-
tration is used, the injection is preferably by the
subcutaneous route using an appropriate pharmaceutical
formulation. Other modes of parenteral administration
such as intraperitoneal, intramuscular, or intravenous
routes are equally effective. In particular, with
intravenous or intramuscular administration, a water
soluble pharmaceutically-acceptable salt is employed.
For oral administration, the compound either as the
free ba=e or in the form of a salt thereof, can also
be mixed with standard pharmaceutical excipients and
loaded into empty telescoping gelatin capsules or
pressed into tablets. The oral dosage range is from
about 0.01 to 10 mg./kg. of mammalian weight and the
parenteral dose range from about 0.0025 to 2.5 mg./kg.
25 Intraperitoneal dosages of 10-100 mg./kg. of trans-
dl-5-n-propyl-4,4a,5,6,7,8,8a,9-octahydro-lH(and
2H)-pyrazolo[3,4-g~quinoline dihydrochloride resulted
in no deaths, but dosages of 300 mg./kg. were fatal,
indicating ar. LD50 in the range 100-300 mg./kg.
